Founded by three friends—each hailing from a different corner of the world—the Brooklyn studio dots is celebrating teamwork, ...
Hands-on, minds-on learning experiences help ensure that students gain a deep understanding of science concepts.
In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug ...
Pharmaceutical and biotech companies are making huge investments in lab automation technologies, but what’s the ROI?
Gen AI tools offer unprecedented opportunities, but organizations adopting them rarely realize significant value right away.
Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry. AI is already rapidly redefining how we discover and design biologics ...
Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.
Following Phase 3 trials, the drug candidate manufacturer can apply for a New Drug Application (NDA) from the FDA. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback